NASDAQ: CRMD
Cormedix Inc Stock Ownership - Who owns Cormedix?

Insider buying vs selling

Have Cormedix Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Steven W. LefkowitzDirector2025-04-0220,000$4.03
$80.60kBuy
Joseph TodiscoChief Executive Officer2025-04-0159,170$3.38
$199.99kBuy
Joseph TodiscoChief Executive Officer2025-01-1723,977$12.17
$291.80kSell
Elizabeth HurlburtEVP2025-01-105,790$11.19
$64.79kSell
Joseph TodiscoChief Executive Officer2025-01-1017,829$11.19
$199.51kSell
Erin MistryEVP Chief Commercial Officer2025-01-105,689$11.19
$63.66kSell
Matthew T. DavidChief Financial Officer2025-01-106,515$11.19
$72.90kSell
Kaufman Beth ZelnickChief Legal Officer2025-01-0211,844$8.22
$97.36kSell
Elizabeth HurlburtEVP2025-01-0211,378$8.22
$93.53kSell
Erin MistryEVP Chief Commercial Officer2025-01-027,830$8.22
$64.36kSell

1 of 3

CRMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRMD insiders and whales buy or sell their stock.

CRMD Shareholders

What type of owners hold Cormedix Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc7.90%5,359,829$69.30MInstitution
Vanguard Group Inc6.38%4,325,545$55.93MInstitution
Gary A. Gelbfish4.04%2,739,743$35.42MInsider
Marshall Wace LLP3.80%2,579,976$33.36MInstitution
Citadel Advisors LLC2.53%1,714,215$22.16MInstitution
State Street Corp2.36%1,601,648$20.71MInstitution
Geode Capital Management LLC2.35%1,596,322$20.64MInstitution
Nuveen LLC2.17%1,468,721$18.99MInstitution
Pharmabio Development Inc1.15%778,563$10.07MInsider
Morgan Stanley1.13%767,253$9.92MInstitution

1 of 3

CRMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRMD50.33%9.81%Net Selling
PGEN23.03%76.97%Net Selling
QURE88.43%11.57%Net SellingNet Selling
IMNM91.25%7.69%Net BuyingNet Buying
AVXL37.59%5.12%Net BuyingNet Buying

Cormedix Stock Ownership FAQ

Who owns Cormedix?

Cormedix (NASDAQ: CRMD) is owned by 50.33% institutional shareholders, 9.81% Cormedix insiders, and 39.86% retail investors. Gary A. Gelbfish is the largest individual Cormedix shareholder, owning 2.74M shares representing 4.04% of the company. Gary A. Gelbfish's Cormedix shares are currently valued at $35.42M.

If you're new to stock investing, here's how to buy Cormedix stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.